Verdikt vs Evalyze: comparing AI startup due diligence platforms.

Verdikt vs Evalyze: a direct comparison for founders deciding which AI startup validation tool to use.

Evalyze and Verdikt both apply AI to the problem of startup due diligence. The category is large enough that two products can occupy the same headline category and still solve meaningfully different jobs. This comparison walks through what each one is built for, how they approach the research methodology, and which one fits which decision.

Evalyze is an AI-powered due diligence platform that automates document review, risk detection, and market validation for startup evaluations. The product is positioned primarily toward investors. The use case is processing a pitch deck, an executive summary, or a data room and producing a structured read on risks, market positioning, and competitive landscape. The output supports the analyst workflow at a venture firm or angel group.

The methodology is optimized for ingesting and structuring documents that a founder has already prepared. The strength of the tool is in extraction and synthesis from the materials a startup has sent to an investor. The output is calibrated for the investor's question: "what do I need to know about this company before the next conversation?"

Verdikt is an AI-powered due diligence platform built primarily around the founder's workflow, with a secondary path for investors. The input is not a pitch deck. The input is a one-sentence pitch plus a structured 9-minute intake interview. The output is a five-section memo with named kill criteria, bottoms-up market sizing, a competitive map, a 10× claim falsifier check, and a full source library.

The methodology is optimized for producing the underlying analysis a founder needs before they have a deck, or for stress-testing the analysis after they do. The strength of the tool is in generating original research rather than summarizing what has already been written. The output is calibrated for the founder's question: "should I build this, and if so, what would kill it."

Evalyze's primary audience is investors. The workflow assumes documents already exist. The tool's value is compressing the time an analyst spends reviewing those documents.

Verdikt's primary audience is founders. The workflow assumes the idea exists but the documents have not been built yet, or the documents that exist were built from conviction rather than research. The tool's value is producing the documents an investor would want to see.

Both audiences benefit from both tools. An investor using Verdikt gets a structured second opinion on the founder's claims that does not depend on the documents the founder chose to share. A founder using Evalyze gets a read on how their pitch deck holds up against AI extraction, which is useful for understanding what an investor analyst will likely conclude from the same document.

Evalyze's methodology is extraction-first. The tool reads the documents a startup has produced, identifies risks, validates claims against external data where possible, and structures the output for investor review. The quality of the analysis depends meaningfully on the quality of the inputs the founder has provided.

Verdikt's methodology is generation-first. The pipeline runs across seven frontier models, pulls from 180+ tier-graded sources, and produces the analysis independently of any documents the founder has prepared. Fourteen quality gates block the memo from shipping if any of them fail. The 10× claim test runs an adversarial pass where a second model tries to break the differentiation claim. The quality of the analysis depends on the rigor of the pipeline, not on the polish of the founder's deck.

Evalyze produces an investor-formatted dashboard with extracted risks, validated claims, and a structured competitive read. The format is built for scanning by an analyst preparing for a partner meeting.

Verdikt produces a one-page memo with a citation pack. The format is built for forwarding: the recommendation is at the top, the named kill criterion is at the bottom, and every claim is traceable to a source. The memo is signed and timestamped, and the three weakest claims ship with one-click re-run hooks for when new evidence appears.

Evalyze's pricing is generally subscription-based for firms that run high volumes of diligence. Pricing tiers and per-evaluation costs are best confirmed on the Evalyze site, as enterprise platforms typically negotiate based on volume and feature scope.

Verdikt's pricing is one-time per verdict. Single Report is $49.99. Founder Pack is $99.99 for three ideas. Cohort engagements (10 or more reports, with white-label exports and portfolio dashboards) for accelerators and VC firms are quoted to scope.

Pick Evalyze when you are an investor or analyst with a pipeline of decks to evaluate and your job is to compress the review time per deal. The extraction-first methodology fits the existing investor workflow, and the output format slots into how venture firms already structure deal memos.

Pick Verdikt when you are a founder evaluating an idea before building, or an investor who wants a structured second opinion on a deal that does not depend on the documents the founder sent. The generation-first methodology produces a defensible memo with named kill criteria, which is useful both pre-build and pre-IC.

Evalyze is built for investors compressing the time spent reading what founders have already written. Verdikt is built for the analysis itself, performed independently of any document, and delivered as a memo with citations and a named kill criterion. For pitch review at scale, Evalyze. For original due diligence on a specific idea, Verdikt.

Evalyze is built for scale. Hundreds or thousands of submissions move through a standardized review pipeline, each scored against a fixed rubric, producing structured feedback in a consistent format. The use case is accelerator screening, investor deal-flow triage, and cohort-level review where the unit of analysis is the cohort, not the individual idea. The cost per submission is low and the output is comparable across submissions.

Verdikt is built for depth. One idea moves through a 5-stage pipeline, with 7 frontier models orchestrated across stages, 14 quality gates blocking ship, and 35 to 50 cited sources weighted by tier. The output is a multi-section memo customized to the specific idea. The cost per submission is higher and the output is bespoke. The use case is the single founder’s "should I build this" decision, or the VC’s second-look on a single pre-screened deal.

The two approaches are not interchangeable. Trying to use Evalyze for decision-grade diligence produces output that is too generic to defend. Trying to use Verdikt at cohort scale exceeds the marginal cost of useful per-cohort signal. Each tool is correct in its lane.

Comparison across submissions is the killer feature. An accelerator’s 200 applications, each scored on the same dimensions, produces a ranked list that human reviewers can use to triage. Without the tool, the same comparison is impossible at scale because human reviewers drift in their scoring as they read the 50th application differently from the 1st.

Consistency over time is another structural win. The same rubric applied across cohorts allows the accelerator to track whether the quality of applications is improving and where the systematic gaps are. That is operational intelligence, not idea-level intelligence, but it is genuinely useful for the operator.

The single-idea, decision-grade memo is the gap. A founder cannot operate from a comparative score; they need to know whether their specific idea has a defensible wedge, a credible TAM, a 10× claim that survives an adversarial test, and a named kill criterion. The score "this idea is in the top quartile of submissions" does not help with the decision; the memo "here is the wedge, here are the substitutes, here is the threshold at which the wedge fails" does.

The same is true for the investor doing a second-look. The accelerator’s screening output narrows the field. The investor still needs an independent memo on the surviving candidates to commit capital. Verdikt is the right tool at that second stage. Evalyze is the right tool at the first.

For an accelerator running a cohort, the right pattern is Evalyze for screening, Verdikt for the top 10 percent of submissions that make it to the deep-dive stage. The two tools sit in sequence, not in competition. The screening tool produces breadth; the diligence tool produces depth. The cost is appropriate at each stage.

For a single founder, Evalyze is not the right tool because the comparison-across-submissions feature is wasted. The founder has one idea. The right tool is Verdikt for the decision moment, supplemented by Y Combinator’s Startup School curriculum for the surrounding learning and a tool like The Mom Test for the customer-development discipline.

Verdikt’s methodology is documented end-to-end so a founder, an accelerator, or an investor can decide where the tool fits in their workflow before they spend any money. The comparison with Evalyze is not adversarial; the tools serve different layers of the same overall problem. The mistake is asking either tool to do the other’s job.